PTEN基因对肺癌作用及治疗的应用研究进展

doi:10.20047/j.issn1673-7210.2023.31.15

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (456 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract PTEN is an important tumor suppressor gene of lung cancer, which inhibits the activation of AKT and mTOR by inhibiting PIP3 production. On the one hand, it directly inhibits tumor cells. On the other hand, it weakens the supporting effect of tumor stroma on tumor cells, and inhibits the occurrence, growth, and metastasis of lung cancer. Decreased expression of PTEN gene leads to the development of drug resistance in lung cancer treatment and reflects the prognosis of patients. However, due to the existence of epigenetic and post-translational regulation, PTEN protein deletion is significantly higher than the incidence of PTEN gene mutation. Therefore, compared with PTEN gene targeting therapy drugs, improving the expression of PTEN protein in lung cancer may be a more promising approach to PTEN gene therapy for lung cancer and inhibiting drug resistance.

Key words： Lung cancer PTEN gene Drug resistance Treatment

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIAO Yang BI Hong JIN Zhixian DU Junyi HUANG Zhaoming CHEN Min

Cite this article:

XIAO Yang BI Hong JIN Zhixian DU Junyi HUANG Zhaoming CHEN Min. Research progress on the effect and therapeutic application of PTEN in lung cancer[J]. 中国医药导报, 2023, 20(31): 72-75.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.31.15 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I31/72

[1] Planchon SM，Waite KA，Eng C. The nuclear affairs of PTEN [J]. J Cell Sci，2008，121（Pt 3）：249-253.
[2] Lázaro S，Lorz C，Enguita AB，et al. Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma [J]. Cancers （Basel），2022，14（15）：3671.
[3] Guo L，Fang L，Liu Y. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer [J]. Eur Rev Med Pharmacol Sci，2019，23（20）：8913- 8920.
[4] Liu L，Huang L，He J，et al. PTEN inhibits non-small cell lung cancer cell growth by promoting G0/G1 arrest and cell apoptosis [J]. Oncol Lett，2019，17（1）：1333-1340.
[5] Perumal E，So Youn K，Sun S，et al. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells [J]. Lung Cancer，2019， 130：25-34.
[6] Yu YX，Wang Y，Liu H. Overexpression of PTEN suppresses non-small-cell lung carcinoma metastasis through inhibition of integrin αVβ6 signaling [J]. Am J Transl Res，2017，9（7）：3304-3314.
[7] Wang M，Zhao M，Guo Q，et al. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN [J]. Exp Cell Res，2021，408（1）：112834.
[8] Qian X，Li X，Shi Z，et al. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1 [J]. Mol Cell，2019，76（3）：516-527.
[9] Xu YJ，Wei RS，Li XH，et al. MiR-421 promotes lipid met- abolism by targeting PTEN via activating PI3K/AKT/mTOR pathway in non-small cell lung cancer [J]. Epigenomics，2022，14（3）：121-138.
[10] Song S，Zhao Y，Fu T，et al. ELANE Promotes M2 Macrop- hage Polarization by Down-Regulating PTEN and Participates in the Lung Cancer Progression [J]. Immunol Invest，2023，52（1）：20-34.
[11] Talb J，Takam Kamga P，Mayenga M，et al. Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab [J]. Cancer Immunol Immunother，2022， 71（11）：2791-2799.
[12] Zhai Y，Chen Q，Wang Y，et al. Down-regulation of HOTAIR Reverses the Resistance of Gefitinib in HCC827 Cells by Increasing the Expression of PTEN [J]. Zhongguo Fei Ai Za Zhi，2020，23（9）：762-771.
[13] Ye C，Lin Q，Zheng C. Overexpressed RBPMS-AS1 increased cell radiosensitivity by sponging miR-19a-3p in lung cancer cell lines （A549 and SK-MES-1） via regulating PTEN/AKT axis [J]. Int J Radiat Biol，2023，2023：1-12.
[14] Shi L，Zhu W，Huang Y，et al. Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer [J]. Clin Transl Med，2022，12（7）：e989.
[15] Yan LD，Yang L，Li N，et al. Prognostic role of multiple abnormal genes in non-small-cell lung cancer [J]. World J Clin Cases，2022，10（22）：7772-7784.
[16] Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers [J]. Nature，2012，489（7417）：519-525.
[17] Viennet T，Rodriguez Ospina S，Lu Y，et al. Chemical and structural approaches to investigate PTEN function and regulation [J]. Methods Enzymol，2023，682：289-318.
[18] Chen H，Wang W，Xiao C，et al. ACY1 regulating PTEN/ PI3K/AKT signaling in the promotion of non-small cell lung cancer progression [J]. Ann Transl Med，2021，9（17）：1378.
[19] He Y，Jiang S，Mao C，et al. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation [J]. J Biol Chem，2021，297（3）：101088.
[20] Liu W，Yan B，Yu H，et al. OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs [J]. Int J Biol Sci，2022，18（4）：1401-1414.
[21] Yu C，Rao D，Wang T，et al. Emerging roles of TRIM27 in cancer and other human diseases [J]. Front Cell Dev Biol，2022，10：1004429.
[22] Chen Y，Yang JL，Xue ZZ，et al. Effects and mechanism of microRNA-218 against lung cancer [J]. Mol Med Rep，2021， 23（1）：28.
[23] Xie Z，Zhong C，Duan S. miR-1269a and miR-1269b：Emerging Carcinogenic Genes of the miR-1269 Family [J]. Front Cell Dev Biol，2022，10：809132.
[24] Wang RQ，Long XR，Zhou NN，et al. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer [J]. J Exp Clin Cancer Res，2021，40（1）：9.
[25] Song X，He J，Shi B，et al. Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non- Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway [J]. Evid Based Complement Alternat Med，2022， 2022：6683104.
[26] Chen Z，Yang J. Growth suppression of human lung cancer cells and implanted tumors by adenovirus-mediated transfer of the PTEN gene [J]. J Huazhong Univ Sci Technolog Med Sci，2010，30（2）：149-154.
[27] Lu L，Fang T，Pang T，et al. The Potential Application of Branch-PCR Assembled PTEN Gene Nanovector in Lung Cancer Gene Therapy [J]. Chembiochem，2022，23（21）：e202200387.
[28] Li D，Zhang Y，Xie Y，et al. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer [J]. Cancer Gene Ther，2013，20（4）：251-259.
[29] Ouyang L，Yang M，Wang X，et al. Long non-coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer [J]. Oncol Rep，2021，45（1）：359-367.
[30] Zou Z，Zhang B，Li Z，et al. KBTBD7 promotes non-small cell lung carcinoma progression by enhancing ubiquitin-dependent degradation of PTEN [J]. Cancer Med，2022， 11（23）：4544-4554.